Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Shares Regain Most Ground Lost on Wednesday s Earnings Plunge

NEW YORK, Oct. 29 (GenomeWeb News) - Shares in Third Wave Technologies yesterday recovered most of the ground they lost on Wednesday, when investors slammed the company despite beating top-line projections for the third quarter.


Third Wave was trading down $.05 at $7.79 on the Nasdaq exchange after nosediving to $5.97 in 30 minutes of heavy trading after the market opened on Wednesday.


At that time, Wall Street was unimpressed with the company's $1.1 million year-over-year revenue growth, which increased to $10.5 million, and beat market expectations. Third Wave also raised its year-end revenue projections, saying it expects to post $43 million in receipts by the end of the year.


The company, which also said it plans to replace CFO David Nuti by the end of the month, spent $2.7 million on R&D expenses for the quarter, compared with $2.8 million last year.


Adam Chazan, who covers Third Wave for Pacific Growth Equities, on Wednesday attributed the stock tumble to the CFO change, as well as to  other management changes the company announced today. He also said investors may have been spooked by Third Wave's 2004 revenue guidance, which he called "conservative."


Third Wave's net income totaled $24,000, representing no earnings per share, compared to a net loss of $1.4 million, or $.04 per diluted share, for the same period last year.


As of Sept. 30, Third Wave had $67.1 million in cash, cash equivalents, and short-term investments.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.